Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies
about
Clinical Applications of Immunotherapy Combination Methods and New Opportunities for the Future.Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials.Trial watch: Immune checkpoint blockers for cancer therapy.How Signaling Molecules Regulate Tumor Microenvironment: Parallels to Wound Repair.Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy.Trial watch: DNA-based vaccines for oncological indications
P2860
Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Phase I clinical trial of comb ...... nts with advanced malignancies
@ast
Phase I clinical trial of comb ...... nts with advanced malignancies
@en
Phase I clinical trial of comb ...... ts with advanced malignancies.
@nl
type
label
Phase I clinical trial of comb ...... nts with advanced malignancies
@ast
Phase I clinical trial of comb ...... nts with advanced malignancies
@en
Phase I clinical trial of comb ...... ts with advanced malignancies.
@nl
prefLabel
Phase I clinical trial of comb ...... nts with advanced malignancies
@ast
Phase I clinical trial of comb ...... nts with advanced malignancies
@en
Phase I clinical trial of comb ...... ts with advanced malignancies.
@nl
P2093
P2860
P50
P1476
Phase I clinical trial of comb ...... nts with advanced malignancies
@en
P2093
Allison Bass
Ann Bailey
Daniel Karp
David S Hong
Gerald Falchook
Luis Vence
Matthew J Reilley
Padmanee Sharma
Sandra Montez
P2860
P2888
P356
10.1186/S40425-017-0238-1
P50
P577
2017-04-18T00:00:00Z
P6179
1084612708